Sim GC - Search Results

1

Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma.

Tseng WW, Malu S, Zhang M, Chen J, Sim GC, Wei W, Ingram D, Somaiah N, Lev DC, Pollock RE, Lizée G, Radvanyi L, Hwu P. Tseng WW, et al. Among authors: sim gc. Sarcoma. 2015;2015:547460. doi: 10.1155/2015/547460. Epub 2015 Jan 29. Sarcoma. 2015. PMID: 25705114 Free PMC article.

2

Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management.

Khoury M, Sim GC, Harao M, Radvanyi L, Amini B, Benjamin RS, Pisters PW, Pollock RE, Tseng WW. Khoury M, et al. Among authors: sim gc. BMJ Case Rep. 2015 Jul 8;2015:bcr2015211218. doi: 10.1136/bcr-2015-211218. BMJ Case Rep. 2015. PMID: 26156843 Free PMC article.

3

Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.

Sim GC, Chacon J, Haymaker C, Ritthipichai K, Singh M, Hwu P, Radvanyi L. Sim GC, et al. BioDrugs. 2014 Oct;28(5):421-37. doi: 10.1007/s40259-014-0097-y. BioDrugs. 2014. PMID: 24890028 Review.

4

The IL-2 cytokine family in cancer immunotherapy.

Sim GC, Radvanyi L. Sim GC, et al. Cytokine Growth Factor Rev. 2014 Aug;25(4):377-90. doi: 10.1016/j.cytogfr.2014.07.018. Epub 2014 Aug 1. Cytokine Growth Factor Rev. 2014. PMID: 25200249 Review.

5

Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.

Sim GC, Wu S, Jin L, Hwu P, Radvanyi LG. Sim GC, et al. Oncotarget. 2016 Jun 14;7(24):36074-36091. doi: 10.18632/oncotarget.8683. Oncotarget. 2016. PMID: 27153543 Free PMC article.

6

IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.

Sim GC, Liu C, Wang E, Liu H, Creasy C, Dai Z, Overwijk WW, Roszik J, Marincola F, Hwu P, Grimm E, Radvanyi L. Sim GC, et al. Cancer Immunol Res. 2016 Nov;4(11):983-994. doi: 10.1158/2326-6066.CIR-15-0195. Epub 2016 Oct 3. Cancer Immunol Res. 2016. PMID: 27697858

7

IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.

Sim GC, Martin-Orozco N, Jin L, Yang Y, Wu S, Washington E, Sanders D, Lacey C, Wang Y, Vence L, Hwu P, Radvanyi L. Sim GC, et al. J Clin Invest. 2014 Jan;124(1):99-110. doi: 10.1172/JCI46266. J Clin Invest. 2014. PMID: 24292706 Free PMC article.

8

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

Paschen A, Sucker A, Hill B, Moll I, Zapatka M, Nguyen XD, Sim GC, Gutmann I, Hassel J, Becker JC, Steinle A, Schadendorf D, Ugurel S. Paschen A, et al. Among authors: sim gc. Clin Cancer Res. 2009 Aug 15;15(16):5208-15. doi: 10.1158/1078-0432.CCR-09-0886. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671853

9

Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia.

Tan YF, Sim GC, Habsah A, Leong CF, Cheong SK. Tan YF, et al. Among authors: sim gc. Malays J Pathol. 2008 Dec;30(2):73-9. Malays J Pathol. 2008. PMID: 19291915 Free article.

10

Comparing the ability of freshly generated and cryopreserved dendritic cell vaccines to inhibit growth of breast cancer in a mouse model.

Radhakrishnan AK, Sim GC, Cheong SK. Radhakrishnan AK, et al. Among authors: sim gc. Biores Open Access. 2012 Oct;1(5):239-46. doi: 10.1089/biores.2012.0229. Biores Open Access. 2012. PMID: 23515111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters